Chi‐Ping Day

National Institutes of Health — United States

Medicine · Health Sciences

22h-index2.9kcitations167works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(30), Immune cells in cancer(25), Immunotherapy and Immune Responses(21), Cancer Genomics and Diagnostics(21), Single-cell and spatial transcriptomics(17)

Publications167 total

Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells
Science Translational Medicine·2026· 1 cited
Connecting spatial regions to clinical phenotypes by transferring knowledge from bulk patient data
2025Open Access
1292 Analysis of single cell transcriptomic profiling uncovers a systematic misidentification of CD8 <sup>+</sup> T and dendritic cells compared to CITE-seq ground truth annotations
Regular and Young Investigator Award Abstracts·2025Open Access
1111 Single-cell-driven design of logic-gated CAR circuits for enhanced solid tumor immunotherapy
Regular and Young Investigator Award Abstracts·2025Open Access
Abstract C042: Systematic discovery of logic-gated cell surface targets for enhanced solid tumor CAR therapy through single-cell transcriptomics
Molecular Cancer Therapeutics·2025
Long-read sequencing of single cell-derived melanoma subclones reveals divergent and parallel genomic and epigenomic evolutionary trajectories
2025Open Access
Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma
Nature Communications·2025· 6 citedOpen Access
Data from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025· 1 citedOpen Access
Supplementary Table 6 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Table 4 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Table 5 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Table 8 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Table 7 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Table 3 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Figure 1 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Figure 3 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Table 1 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Figure 2 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Table 2 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
Supplementary Figure 4 from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
2025Open Access
page 1 of 9Next →

Frequent Co-authors

Glenn Merlino(31), Eva Pérez‐Guijarro(14), Kerrie L. Marie(9), Maxwell P. Lee(7), Eytan Ruppin(6), Helen Michael(6), Salem Malikić(6), Terry Van Dyke(5), Farid Rashidi Mehrabadi(5), Howard H. Yang(4), Rajaâ El Meskini(4), Cari Smith(4), Sung Chin(4), Zoë Weaver Ohler(4), M. Raza Zaidi(4), Antonella Sassano(4), Kenneth Aldape(4), Sridhar Hannenhalli(4), Alejandro A. Schäffer(4), Nishanth Ulhas Nair(4)